Term	Overlap	P-value	Adjusted P-value	Old P-value	Old Adjusted P-value	Odds Ratio	Combined Score	Genes
TYROBP Causal Network WP3945	11/61	2.9463754389143905E-7	1.3906892071675924E-4	0	0	7.198717319459442	108.2508549516682	PYCARD;CD4;ITGAM;TYROBP;ADAP2;BIN2;ITGB2;RPS6KA1;RNASE6;CD37;TCIRG1
Human Complement System WP2806	11/97	3.1163355090490574E-5	0.007354551801355775	0	0	4.52702841739202	46.97365860748828	FCN2;FKBP2;CR1;ITGA2;ITGB2;FPR1;WAS;CD59;TXN;PRKACA;GNAI2
Microglia Pathogen Phagocytosis Pathway WP3937	5/40	0.0030866933404009498	0.4856397522230828	0	0	4.990019960079841	28.845583220713163	ITGAM;TYROBP;ARPC1B;ITGB2;NCF4
Integrin-mediated Cell Adhesion WP185	8/101	0.0038753602156586936	0.4572925054477258	0	0	3.161992845991186	17.558915156989222	ITGAM;CAPNS1;AKT2;ITGA2;ITGB2;ITGAV;TLN1;MAP2K6
Fatty Acid Omega Oxidation WP206	3/15	0.005679481062252484	0.5361430122766345	0	0	7.984031936127745	41.28459411339207	ALDH2;ALDH1A1;CYP1A1
B Cell Receptor Signaling Pathway WP23	7/97	0.011009910534233716	0.8661129620263855	0	0	2.8808362656131035	12.989573915679674	PTPN18;GSK3A;IRF4;RPS6KA1;SH3BP2;BTK;MAP2K6
NRF2 pathway WP2884	9/146	0.01139825927442449	0.7685683396469084	0	0	2.4608317611352635	11.010486335329452	HGF;TXNRD1;SLC39A11;TXN;GCLM;SQSTM1;SLC5A3;SLC39A14;SLC6A3
Glycogen Synthesis and Degradation WP500	4/40	0.017447713960811927	1.0	0	0	3.9920159680638725	16.161862850405928	PPP2CB;GSK3A;CALM3;PYGL
Thiamine metabolic pathways WP4297	2/9	0.020062908617707677	1.0	0	0	8.871146595697494	34.67626978098511	BCKDK;TKT
Calcium Regulation in the Cardiac Cell WP536	8/149	0.0342347022969802	1.0	0	0	2.143364278155099	7.232815898006512	PKIA;ANXA6;ADCY3;CALM3;ARRB1;CAMK1;PRKACA;GNAI2
Development of pulmonary dendritic cells and macrophage subsets WP3892	2/13	0.04069787289446008	1.0	0	0	6.141563027790573	19.66270198639476	SPI1;IRF4
Dopamine metabolism WP2436	2/13	0.04069787289446008	1.0	0	0	6.141563027790573	19.66270198639476	PPP2CB;PRKACA
RANKL/RANK (Receptor activator of NFKB (ligand)) Signaling Pathway WP2018	4/55	0.04873844210875919	1.0	0	0	2.9032843404100888	8.771655799951775	SPI1;AKT2;SQSTM1;MAP2K6
Prion disease pathway WP3995	3/33	0.048945080912139005	1.0	0	0	3.6291054255126114	10.94921577625266	PDIA3;SPI1;IRF4
Fibrin Complement Receptor 3 Signaling Pathway WP4136	3/37	0.06484412464483195	1.0	0	0	3.2367697038355723	8.855054123575064	ITGAM;TYROBP;ITGB2
Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664	2/17	0.06647430838637498	1.0	0	0	4.696489374192791	12.731899711275735	LRP1;FZD7
Parkinsons Disease Pathway WP2371	3/38	0.06914630038031797	1.0	0	0	3.1515915537346357	8.419573664266768	CCNE2;SLC6A3;UBE2J1
Ferroptosis WP4313	3/40	0.07812499551630382	1.0	0	0	2.9940119760479043	7.633069545858934	PCBP1;GCLM;SLC39A14
IL-5 Signaling Pathway WP127	3/40	0.07812499551630382	1.0	0	0	2.9940119760479043	7.633069545858934	GSK3A;RPS6KA1;BTK
Human Thyroid Stimulating Hormone (TSH) signaling pathway WP2032	4/66	0.08352654617625484	1.0	0	0	2.4194036170084074	6.006389111164661	RPS6KA1;ADCY3;GNAI2;MAP2K6
Vitamin A and Carotenoid Metabolism WP716	3/43	0.09248536094933953	1.0	0	0	2.785127419579446	6.63056651440004	RBP7;ALDH1A1;CD36
Prostaglandin Synthesis and Regulation WP98	3/45	0.10261818222605365	1.0	0	0	2.6613439787092483	6.0591886820153	TBXAS1;ANXA6;PPARGC1B
Methionine De Novo and Salvage Pathway WP3580	2/22	0.10414388425205447	1.0	0	0	3.6291054255126114	8.208970544637436	MSRA;TXN
NAD+ biosynthetic pathways WP3645	2/22	0.10414388425205447	1.0	0	0	3.6291054255126114	8.208970544637436	BST1;NADSYN1
Tryptophan metabolism WP465	3/46	0.10784284389531121	1.0	0	0	2.6034886748242645	5.798178236743239	ALDH2;ALDH1A1;CYP1A1
Chemokine signaling pathway WP3929	7/164	0.11873908175508928	1.0	0	0	1.703909254661409	3.630735476331766	AKT2;WAS;ADCY3;ARRB1;RASGRP2;CCL27;GNAI2
Secretion of Hydrochloric Acid in Parietal Cells WP2597	1/5	0.11914118820093654	1.0	0	0	7.984031936127745	16.98559707531037	HRH2
Sulindac Metabolic Pathway WP2542	1/5	0.11914118820093654	1.0	0	0	7.984031936127745	16.98559707531037	MSRA
Differentiation of white and brown adipocyte    WP2895	2/25	0.12890842246783948	1.0	0	0	3.193612774451098	6.542604487253486	PLAC8;PPARGC1B
Signal Transduction of S1P Receptor WP26	2/25	0.12890842246783948	1.0	0	0	3.193612774451098	6.542604487253486	AKT2;GNAI2
Canonical  and Non-canonical Notch signaling WP3845	2/27	0.1460968920179745	1.0	0	0	2.957048865232498	5.687839826803707	MFAP1;DLK2
Eicosanoid Synthesis WP167	2/27	0.1460968920179745	1.0	0	0	2.957048865232498	5.687839826803707	ALOX5;TBXAS1
Intraflagellar transport proteins binding to dynein WP4532	2/27	0.1460968920179745	1.0	0	0	2.957048865232498	5.687839826803707	WDR19;IFT46
Viral Acute Myocarditis WP4298	4/84	0.1596061994243345	1.0	0	0	1.90095998479232	3.488348543313279	PYCARD;CD4;ITGB2;AIF1
Hfe effect on hepcidin production WP3924	1/7	0.16273124584464063	1.0	0	0	5.70287995437696	10.35446385764878	HFE
Pentose Phosphate Metabolism WP134	1/7	0.16273124584464063	1.0	0	0	5.70287995437696	10.35446385764878	TKT
Cannabinoid receptor signaling WP3869	2/29	0.1637191408036955	1.0	0	0	2.753114460733705	4.982043844265942	CYP1A1;PRKACA
Lipid Metabolism Pathway WP3965	2/29	0.1637191408036955	1.0	0	0	2.753114460733705	4.982043844265942	AKT2;PRKACA
Pyrimidine metabolism WP4022	4/85	0.16441431113798552	1.0	0	0	1.8785957496771164	3.391552423493865	CDA;POLR2D;TK2;POLR2J
MAPK Signaling Pathway WP382	9/246	0.1661566087951338	1.0	0	0	1.4604936468526362	2.621329792457924	DUSP10;AKT2;CACNA2D3;ARRB1;HSPA2;PRKACA;RASGRP2;RASGRP4;MAP2K6
Dopaminergic Neurogenesis WP2855	2/30	0.1726661568608228	1.0	0	0	2.6613439787092483	4.674371997175302	ALDH1A1;SLC6A3
Vitamin D Receptor Pathway WP2877	7/182	0.17330831680665879	1.0	0	0	1.5353907569476433	2.6910534202460004	CDKN2D;ITGAM;DUSP10;IRF4;ALOX5;CYP1A1;S100A8
Nuclear Receptors Meta-Pathway WP2882	11/319	0.17904587851604314	1.0	0	0	1.3765572303668525	2.367834264468145	FGD4;HGF;TXNRD1;CYP1A1;SLC39A11;TXN;GCLM;SLC5A3;SLC39A14;SQSTM1;SLC6A3
Ethanol effects on histone modifications WP3996	2/31	0.18169041858172108	1.0	0	0	2.575494172944434	4.392379208156024	ALDH2;ALDH1A1
Hippo-Merlin Signaling Dysregulation WP4541	5/120	0.18308013845221566	1.0	0	0	1.66333998669328	2.8240707035231094	ITGAM;ITGA2;ITGB2;ITGAV;PRKACA
ApoE and miR-146 in inflammation and atherosclerosis WP3926	1/8	0.18371214190848226	1.0	0	0	4.990019960079841	8.455015930870282	SPI1
Insulin signalling in human adipocytes (diabetic condition) WP3635	1/8	0.18371214190848226	1.0	0	0	4.990019960079841	8.455015930870282	AKT2
Insulin signalling in human adipocytes (normal condition) WP3634	1/8	0.18371214190848226	1.0	0	0	4.990019960079841	8.455015930870282	AKT2
NAD Biosynthesis II (from tryptophan) WP2485	1/8	0.18371214190848226	1.0	0	0	4.990019960079841	8.455015930870282	NADSYN1
Phase I biotransformations, non P450 WP136	1/8	0.18371214190848226	1.0	0	0	4.990019960079841	8.455015930870282	LIPA
TFs Regulate miRNAs related to cardiac hypertrophy WP1559	1/8	0.18371214190848226	1.0	0	0	4.990019960079841	8.455015930870282	AKT2
Cytoplasmic Ribosomal Proteins WP477	4/89	0.18414653702587402	1.0	0	0	1.7941644800287067	3.0357683580239536	RPS28;RPS6KA1;RPL36A;RPS10
T-Cell antigen Receptor (TCR)  Signaling Pathway WP69	4/90	0.18919676125363832	1.0	0	0	1.7742293191394989	2.954034580830534	CD4;IRF4;WAS;CD3E
Monoamine Transport WP727	2/32	0.1907824676590054	1.0	0	0	2.4950099800399204	4.133286958007988	PPP2CB;SLC6A3
Myometrial Relaxation and Contraction Pathways WP289	6/156	0.19782292757796469	1.0	0	0	1.5353907569476433	2.4879210096404636	CNN2;PKIA;ADCY3;CALM3;ARRB1;PRKACA
Oxidative Stress WP408	2/33	0.19993326943321624	1.0	0	0	2.4194036170084074	3.8946872822657967	TXNRD1;CYP1A1
Benzo(a)pyrene metabolism WP696	1/9	0.20416830651228607	1.0	0	0	4.435573297848747	7.047285843276598	CYP1A1
Degradation pathway of sphingolipids, including diseases WP4153	1/9	0.20416830651228607	1.0	0	0	4.435573297848747	7.047285843276598	GLA
Folate-Alcohol and Cancer Pathway Hypotheses WP1589	1/9	0.20416830651228607	1.0	0	0	4.435573297848747	7.047285843276598	ALDH1A1
Tgif disruption of Shh signaling WP3674	1/9	0.20416830651228607	1.0	0	0	4.435573297848747	7.047285843276598	TGIF1
G Protein Signaling Pathways WP35	4/93	0.2046035355662503	1.0	0	0	1.7169961152962894	2.7243253625762844	AKAP7;ADCY3;PRKACA;GNAI2
BDNF-TrkB Signaling WP3676	2/34	0.20913419759586005	1.0	0	0	2.3482446870963956	3.6744843003668644	HOMER1;RPS6KA1
Ebola Virus Pathway on Host WP4217	5/129	0.22277237342314624	1.0	0	0	1.5472930108774698	2.3234225747271515	BST2;GSN;ITGA2;ITGAV;ASGR1
Interleukin-1 Induced Activation of NF-kappa-B WP3656	1/10	0.22411283742595428	1.0	0	0	3.9920159680638725	5.970481498810472	SQSTM1
Trans-sulfuration pathway WP2333	1/10	0.22411283742595428	1.0	0	0	3.9920159680638725	5.970481498810472	GCLM
Zinc homeostasis WP3529	2/36	0.22765388244637488	1.0	0	0	2.2177866489243736	3.2821664734821803	SLC39A11;SLC39A14
Focal Adhesion WP306	7/198	0.22926575501814744	1.0	0	0	1.4113187765882376	2.0786939499167962	AKT2;HGF;ITGA2;TESK2;ITGAV;TLN1;MYL12A
Angiopoietin Like Protein 8 Regulatory Pathway WP3915	5/132	0.23654683286935366	1.0	0	0	1.5121272606302547	2.179896367623711	GSK3A;AKT2;RPS6KA1;FBP1;MAP2K6
Type II interferon signaling (IFNG) WP619	2/37	0.23695729856562672	1.0	0	0	2.1578464692237147	3.1070298946086625	SPI1;IRF4
Serotonin Transporter Activity WP1455	1/11	0.24355850601349568	1.0	0	0	3.6291054255126114	5.125741586707747	PPP2CB
Sterol Regulatory Element-Binding Proteins (SREBP) signalling WP1982	3/69	0.24923071208031164	1.0	0	0	1.7356591165495097	2.4114835667182444	GSK3A;PRKACA;PPARGC1B
MAPK  and NFkB Signalling Pathways Inhibited by Yersinia YopJ WP3849	1/12	0.26251776563299406	1.0	0	0	3.32667997338656	4.449223288884464	MAP2K6
Ectoderm Differentiation WP2858	5/138	0.2647561981522648	1.0	0	0	1.4463825971245914	1.9221641983202624	BCOR;ZBTB7B;SKIL;WDR44;AES
Bladder Cancer WP2828	2/40	0.2649572005591817	1.0	0	0	1.9960079840319362	2.6510718031206983	RASSF1;UPK3A
Regulation of toll-like receptor signaling pathway WP1449	5/139	0.269532156373308	1.0	0	0	1.4359769669294504	1.882662842820296	AKT2;BTK;SQSTM1;CTNNAL1;MAP2K6
Primary Focal Segmental Glomerulosclerosis FSGS WP2572	3/72	0.269546132667652	1.0	0	0	1.66333998669328	2.180664877832336	CR1;ITGAV;TLN1
Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433	2/41	0.2742988114577582	1.0	0	0	1.9473248624701818	2.518937177448446	PYCARD;CARD9
Estrogen Receptor Pathway WP2881	1/13	0.28100275937671115	1.0	0	0	3.0707815138952865	3.8980217713823384	CYP1A1
Kennedy pathway from Sphingolipids WP3933	1/13	0.28100275937671115	1.0	0	0	3.0707815138952865	3.8980217713823384	CHKB
MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301	1/13	0.28100275937671115	1.0	0	0	3.0707815138952865	3.8980217713823384	ITGAV
Osteopontin Signaling WP1434	1/13	0.28100275937671115	1.0	0	0	3.0707815138952865	3.8980217713823384	ITGAV
Arrhythmogenic Right Ventricular Cardiomyopathy WP2118	3/74	0.28319172085683497	1.0	0	0	1.6183848519177861	2.041804744865658	ITGA2;CACNA2D3;ITGAV
Thermogenesis WP4321	4/108	0.2860612244139643	1.0	0	0	1.478524432616249	1.850446395645442	RPS6KA1;ADCY3;PRKACA;CREB5
H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969	1/14	0.2990253277648604	1.0	0	0	2.85143997718848	3.4423353320083003	TULP3
Osteoblast Signaling WP322	1/14	0.2990253277648604	1.0	0	0	2.85143997718848	3.4423353320083003	ITGAV
Hedgehog Signaling Pathway WP4249	2/44	0.3022665887279757	1.0	0	0	1.8145527127563057	2.171014165966906	ARRB1;PRKACA
Interleukin-11 Signaling Pathway WP2332	2/44	0.3022665887279757	1.0	0	0	1.8145527127563057	2.171014165966906	ITGA2;RPS6KA1
Ras Signaling WP4223	6/184	0.3146182928126854	1.0	0	0	1.3017443374121322	1.5053308302403625	RASSF1;AKT2;CALM3;PRKACA;RASGRP2;RASGRP4
Phytochemical activity on NRF2 transcriptional activation WP3	1/15	0.31659701631763015	1.0	0	0	2.6613439787092483	3.0608797224710957	GCLM
Aryl Hydrocarbon Receptor WP2586	2/46	0.3208120922355896	1.0	0	0	1.7356591165495097	1.9732703457414982	CYP1A1;CD36
Regulation of Microtubule Cytoskeleton WP2038	2/46	0.3208120922355896	1.0	0	0	1.7356591165495097	1.9732703457414982	TESK2;PRKACA
Energy Metabolism WP1541	2/47	0.3300406877463518	1.0	0	0	1.698730199176116	1.8831092469034643	UCP2;PPARGC1B
Tryptophan catabolism leading to NAD+ production WP4210	1/16	0.3337290829297504	1.0	0	0	2.4950099800399204	2.738088183885644	NADSYN1
Cells and Molecules involved in local acute inflammatory response  WP4493	1/17	0.35043250486752237	1.0	0	0	2.3482446870963956	2.462339225524074	ITGB2
Synaptic signaling pathways associated with autism spectrum disorder WP4539	2/50	0.35749945444271564	1.0	0	0	1.596806387225549	1.6425092900336942	HOMER1;AKT2
Selenium Micronutrient Network WP15	3/86	0.36559974414510454	1.0	0	0	1.392563709789723	1.4012200796884993	ALOX5;TXNRD1;TXN
4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879	1/18	0.3667179858776594	1.0	0	0	2.2177866489243736	2.224799638884351	MAP2K6
Estrogen metabolism WP697	1/18	0.3667179858776594	1.0	0	0	2.2177866489243736	2.224799638884351	CYP1A1
Transcription co-factors SKI and SKIL protein partners WP4533	1/18	0.3667179858776594	1.0	0	0	2.2177866489243736	2.224799638884351	SKIL
Insulin Signaling WP481	5/160	0.3727197611966399	1.0	0	0	1.2475049900199602	1.2311981688850353	GSK3A;AKT2;RPS6KA1;INPPL1;MAP2K6
One carbon metabolism and related pathways WP3940	2/52	0.375578614654909	1.0	0	0	1.5353907569476433	1.5035889294603109	CHKB;GCLM
Mitochondrial Gene Expression WP391	1/19	0.3825959630846926	1.0	0	0	2.101061035823091	2.0186485414436297	PPARGC1B
Small Ligand GPCRs WP247	1/19	0.3825959630846926	1.0	0	0	2.101061035823091	2.0186485414436297	PTAFR
TGF-beta Receptor Signaling WP560	2/54	0.3934453041199751	1.0	0	0	1.478524432616249	1.379187135669868	TGIF1;SKIL
Urea cycle and metabolism of amino groups WP497	1/20	0.3980766131386796	1.0	0	0	1.9960079840319362	1.8385445047888849	ARG2
Amino Acid metabolism WP3925	3/91	0.39962211042160095	1.0	0	0	1.3160492202408371	1.2071275940686657	ARG2;ALDH1A1;GCLM
Cardiac Hypertrophic Response WP2795	2/55	0.40229160237612244	1.0	0	0	1.4516421702050444	1.3218335318864214	AKT2;MAP2K6
DNA IR-Double Strand Breaks (DSBs) and cellular response via ATM WP3959	2/55	0.40229160237612244	1.0	0	0	1.4516421702050444	1.3218335318864214	RASSF1;TP53BP1
Hematopoietic Stem Cell Differentiation WP2849	2/55	0.40229160237612244	1.0	0	0	1.4516421702050444	1.3218335318864214	SPI1;CBFA2T3
IL-1 signaling pathway WP195	2/55	0.40229160237612244	1.0	0	0	1.4516421702050444	1.3218335318864214	SQSTM1;MAP2K6
Pathogenic Escherichia coli infection WP2272	2/55	0.40229160237612244	1.0	0	0	1.4516421702050444	1.3218335318864214	ARPC1B;WAS
TNF alpha Signaling Pathway WP231	3/92	0.40637026381050545	1.0	0	0	1.3017443374121322	1.172208481062896	PYGL;TXN;MAP2K6
Glycerophospholipid Biosynthetic Pathway WP2533	1/21	0.41316985938893996	1.0	0	0	1.90095998479232	1.6802518558328536	CHKB
Nicotine Activity on Dopaminergic Neurons WP1602	1/21	0.41316985938893996	1.0	0	0	1.90095998479232	1.6802518558328536	PRKACA
Tamoxifen metabolism WP691	1/21	0.41316985938893996	1.0	0	0	1.90095998479232	1.6802518558328536	CYP1A1
TGF-beta Signaling Pathway WP366	4/132	0.4221795033326523	1.0	0	0	1.2097018085042037	1.0431557394785587	TGIF1;ITGA2;SKIL;MAP2K6
Regulation of Apoptosis by Parathyroid Hormone-related Protein WP3872	1/22	0.4278853777269616	1.0	0	0	1.8145527127563057	1.5403736677857789	GSK3A
Vitamin D in inflammatory diseases WP4482	1/22	0.4278853777269616	1.0	0	0	1.8145527127563057	1.5403736677857789	MAP2K6
Preimplantation Embryo WP3527	2/58	0.4284511821864397	1.0	0	0	1.3765572303668525	1.166740277588288	IRF4;KHSRP
Kit receptor signaling pathway WP304	2/59	0.4370369158685498	1.0	0	0	1.3532257518860584	1.1201158520689831	RPS6KA1;BTK
MET in type 1 papillary renal cell carcinoma WP4205	2/59	0.4370369158685498	1.0	0	0	1.3532257518860584	1.1201158520689831	AKT2;HGF
Estrogen signaling pathway WP712	1/23	0.44223260270614745	1.0	0	0	1.7356591165495097	1.4161577451345275	PRKACA
Glutathione metabolism WP100	1/23	0.44223260270614745	1.0	0	0	1.7356591165495097	1.4161577451345275	GCLM
Hippo-Yap signaling pathway WP4537	1/23	0.44223260270614745	1.0	0	0	1.7356591165495097	1.4161577451345275	RASSF1
NRF2-ARE regulation WP4357	1/23	0.44223260270614745	1.0	0	0	1.7356591165495097	1.4161577451345275	GCLM
The human immune response to tuberculosis WP4197	1/23	0.44223260270614745	1.0	0	0	1.7356591165495097	1.4161577451345275	PSMB8
Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612	1/24	0.45622073398587787	1.0	0	0	1.66333998669328	1.3053534943966754	GCLM
Proteasome Degradation WP183	2/62	0.4623636892913102	1.0	0	0	1.287747086472217	0.9933725984501766	PSMB10;PSMB8
Glycosylation and related congenital defects. WP4521	1/25	0.46985874151578455	1.0	0	0	1.596806387225549	1.206104877315196	DOLK
Lung fibrosis WP3624	2/63	0.4706567293691487	1.0	0	0	1.2673066565282134	0.9550755797082654	HGF;SKIL
Wnt Signaling Pathway and Pluripotency WP399	3/102	0.47237242296345255	1.0	0	0	1.1741223435481978	0.880577166627004	PPP2CB;FZD7;NKD1
Electron Transport Chain (OXPHOS system in mitochondria) WP111	3/103	0.47879587838583765	1.0	0	0	1.162723097494332	0.8563233690507335	UCP2;COX6C;SLC25A6
Genes related to primary cilium development (based on CRISPR) WP4536	3/103	0.47879587838583765	1.0	0	0	1.162723097494332	0.8563233690507335	WDR19;TULP3;IFT46
Endochondral Ossification WP474	2/64	0.47887261507073575	1.0	0	0	1.2475049900199602	0.9185636929252488	PRKACA;CST5
G1 to S cell cycle control WP45	2/64	0.47887261507073575	1.0	0	0	1.2475049900199602	0.9185636929252488	CDKN2D;CCNE2
Cytokines and Inflammatory Response WP530	1/26	0.4831553719844761	1.0	0	0	1.5353907569476433	1.1168693319984115	CD4
Glucuronidation WP698	1/26	0.4831553719844761	1.0	0	0	1.5353907569476433	1.1168693319984115	PGM3
Brain-Derived Neurotrophic Factor (BDNF) signaling pathway WP2380	4/144	0.4883976615004827	1.0	0	0	1.1088933244621868	0.7946610388551787	SORT1;RPS6KA1;CAMK1;SQSTM1
Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932	8/303	0.4902480141833111	1.0	0	0	1.0539976153303954	0.7513357333221213	PPP2CB;AKT2;HGF;ITGA2;ITGB2;ITGAV;PELO;CREB5
Senescence and Autophagy in Cancer WP615	3/105	0.49153150689000524	1.0	0	0	1.140575990875392	0.8100704167770358	GSN;SQSTM1;GABARAP
Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680	2/66	0.4950676650272665	1.0	0	0	1.2097018085042037	0.8504939560041769	FZD7;CAMK1
Non-small cell lung cancer WP4255	2/66	0.4950676650272665	1.0	0	0	1.2097018085042037	0.8504939560041769	RASSF1;AKT2
Follicle Stimulating Hormone (FSH) signaling pathway WP2035	1/27	0.4961191537584301	1.0	0	0	1.478524432616249	1.0363556616485345	PRKACA
PPAR signaling pathway WP3942	2/67	0.5030444836066243	1.0	0	0	1.1916465576310067	0.8187525560210878	FADS2;CD36
Nanoparticle-mediated activation of receptor signaling WP2643	1/28	0.5087584025574095	1.0	0	0	1.42571998859424	0.9634759427977776	TLN1
AMP-activated Protein Kinase (AMPK) Signaling WP1403	2/69	0.518751643700429	1.0	0	0	1.157106077699673	0.7594434769453656	AKT2;PPARGC1B
Gastric Cancer Network 1 WP2361	1/29	0.5210812269415764	1.0	0	0	1.3765572303668525	0.8973079269638153	KIF20B
MAPK Cascade WP422	1/29	0.5210812269415764	1.0	0	0	1.3765572303668525	0.8973079269638153	MAP2K6
Selective expression of chemokine receptors during T-cell polarization WP4494	1/29	0.5210812269415764	1.0	0	0	1.3765572303668525	0.8973079269638153	CD4
Statin Pathway WP430	1/29	0.5210812269415764	1.0	0	0	1.3765572303668525	0.8973079269638153	LRP1
T-Cell Receptor and Co-stimulatory Signaling WP2583	1/29	0.5210812269415764	1.0	0	0	1.3765572303668525	0.8973079269638153	GSK3A
miRs in Muscle Cell Differentiation WP2012	1/29	0.5210812269415764	1.0	0	0	1.3765572303668525	0.8973079269638153	PRKACA
Parkin-Ubiquitin Proteasomal System pathway WP2359	2/70	0.5264802604290403	1.0	0	0	1.140575990875392	0.7317267638135767	HSPA2;UBE2J1
Extracellular vesicle-mediated signaling in recipient cells WP2870	1/30	0.5330955331325007	1.0	0	0	1.3306719893546242	0.8370653815448016	HGF
GABA receptor Signaling WP4159	1/31	0.5448090301709836	1.0	0	0	1.287747086472217	0.7820744949848526	AP2S1
Gastric Cancer Network 2 WP2363	1/31	0.5448090301709836	1.0	0	0	1.287747086472217	0.7820744949848526	PLAC8
Trans-sulfuration and one carbon metabolism WP2525	1/31	0.5448090301709836	1.0	0	0	1.287747086472217	0.7820744949848526	GCLM
White fat cell differentiation WP4149	1/32	0.5562292348897921	1.0	0	0	1.2475049900199602	0.7317549609951273	IRF4
ESC Pluripotency Pathways WP3931	3/116	0.5586312620232661	1.0	0	0	1.0324179227751393	0.6011415053511345	AKT2;FZD7;MAP2K6
Fluoropyrimidine Activity WP1601	1/33	0.5673634767849206	1.0	0	0	1.2097018085042037	0.6856047034537754	CDA
Monoamine GPCRs WP58	1/33	0.5673634767849206	1.0	0	0	1.2097018085042037	0.6856047034537754	HRH2
Resistin as a regulator of inflammation WP4481	1/33	0.5673634767849206	1.0	0	0	1.2097018085042037	0.6856047034537754	AKT2
Signal transduction through IL1R WP4496	1/33	0.5673634767849206	1.0	0	0	1.2097018085042037	0.6856047034537754	MAP2K6
Leptin signaling pathway WP2034	2/76	0.571062332712876	1.0	0	0	1.0505305179115454	0.5885669830480854	GSK3A;RPS6KA1
Fatty Acid Beta Oxidation WP143	1/34	0.5782189022057896	1.0	0	0	1.1741223435481978	0.6431874585746026	CHKB
Signaling of Hepatocyte Growth Factor Receptor WP313	1/34	0.5782189022057896	1.0	0	0	1.1741223435481978	0.6431874585746026	HGF
p38 MAPK Signaling Pathway WP400	1/34	0.5782189022057896	1.0	0	0	1.1741223435481978	0.6431874585746026	MAP2K6
EGF/EGFR Signaling Pathway WP437	4/162	0.5812014896871904	1.0	0	0	0.9856829550774993	0.5348885282926661	IQSEC1;RPS6KA1;INPPL1;AP2S1
Wnt Signaling in Kidney Disease WP4150	1/36	0.599121003573457	1.0	0	0	1.1088933244621868	0.5680768373954505	FZD7
Melatonin metabolism and effects WP3298	1/37	0.609181098864309	1.0	0	0	1.0789232346118574	0.5347571717115402	CYP1A1
Photodynamic therapy-induced HIF-1 survival signaling WP3614	1/37	0.609181098864309	1.0	0	0	1.0789232346118574	0.5347571717115402	SLC16A1
The effect of progerin on the involved genes in Hutchinson-Gilford Progeria Syndrome WP4320	1/37	0.609181098864309	1.0	0	0	1.0789232346118574	0.5347571717115402	MTA2
Signaling Pathways in Glioblastoma WP2261	2/82	0.6125226703792012	1.0	0	0	0.9736624312350909	0.477259456096794	AKT2;MAP2K6
Amyotrophic lateral sclerosis (ALS) WP2447	1/38	0.6189892254204357	1.0	0	0	1.0505305179115454	0.5039052556760754	MAP2K6
Alzheimers Disease WP2059	2/83	0.6191275493053049	1.0	0	0	0.9619315585696079	0.46119228577865223	LRP1;CALM3
MicroRNAs in cardiomyocyte hypertrophy WP1544	2/84	0.6256454788833774	1.0	0	0	0.95047999239616	0.44574792887411535	AKT2;MAP2K6
G13 Signaling Pathway WP524	1/39	0.6285516817214095	1.0	0	0	1.0235938379650955	0.4752925165748353	WAS
Pathways in clear cell renal cell carcinoma WP4018	2/85	0.6320766618609884	1.0	0	0	0.9392978748385582	0.4308978201513429	CAMK1;SQSTM1
Ciliary landscape WP4352	5/216	0.632487414442528	1.0	0	0	0.9240777703851556	0.4233153662055631	MFAP1;CDH23;COX6C;IFT46;GLA
ATM Signaling Pathway WP2516	1/40	0.6378746091940292	1.0	0	0	0.9980039920159681	0.4487161200267164	TP53BP1
ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336	2/86	0.6384213450647823	1.0	0	0	0.9283758065264819	0.41661495442011937	FZD7;NKD1
Common Pathways Underlying Drug Addiction WP2636	1/42	0.655825681395399	1.0	0	0	0.95047999239616	0.40096973189867235	PRKACA
Metabolic reprogramming in colon cancer WP4290	1/42	0.655825681395399	1.0	0	0	0.95047999239616	0.40096973189867235	TKT
TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036	1/42	0.655825681395399	1.0	0	0	0.95047999239616	0.40096973189867235	AKT2
Androgen receptor signaling pathway WP138	2/90	0.662941444636234	1.0	0	0	0.8871146595697494	0.36466499134677594	TGIF1;AES
Eukaryotic Transcription Initiation WP405	1/43	0.6644653579467766	1.0	0	0	0.9283758065264819	0.3794945315863879	POLR2J
Apoptosis Modulation and Signaling WP1772	2/91	0.6688587275075311	1.0	0	0	0.8773661468272248	0.3528612320837916	CAPNS1;TNFRSF10C
Corticotropin-releasing hormone signaling pathway WP2355	2/93	0.680441155496539	1.0	0	0	0.8584980576481447	0.3305337137178465	ARRB1;GNAI2
ATM Signaling Network in Development and Disease  WP3878	1/45	0.6811007508703733	1.0	0	0	0.8871146595697494	0.3406919834089068	TP53BP1
Glycolysis and Gluconeogenesis WP534	1/45	0.6811007508703733	1.0	0	0	0.8871146595697494	0.3406919834089068	FBP1
LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258	2/94	0.6861073218285061	1.0	0	0	0.849365099588058	0.31997385457041083	FZD7;NKD1
Aryl Hydrocarbon Receptor Pathway WP2873	1/46	0.689107157238874	1.0	0	0	0.8678295582747548	0.3231437076416972	CYP1A1
Selenium Metabolism and Selenoproteins WP28	1/46	0.689107157238874	1.0	0	0	0.8678295582747548	0.3231437076416972	TXNRD1
Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534	1/47	0.6969129416001711	1.0	0	0	0.849365099588058	0.30670130417480823	ITGB2
Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203	1/47	0.6969129416001711	1.0	0	0	0.849365099588058	0.30670130417480823	BTK
Differentiation Pathway WP2848	1/48	0.7045231214628878	1.0	0	0	0.83166999334664	0.2912792153229621	HGF
Exercise-induced Circadian Regulation WP410	1/48	0.7045231214628878	1.0	0	0	0.83166999334664	0.2912792153229621	PPP2CB
Pathways Regulating Hippo Signaling WP4540	2/98	0.7079514620820376	1.0	0	0	0.8146971363395658	0.2813798884026365	PRKACA;GNAI2
IL-3 Signaling Pathway WP286	1/49	0.7119425888293248	1.0	0	0	0.8146971363395658	0.2767998733047446	PRKACA
Structural Pathway of Interleukin 1 (IL-1) WP2637	1/49	0.7119425888293248	1.0	0	0	0.8146971363395658	0.2767998733047446	MAP2K6
Photodynamic therapy-induced AP-1 survival signaling. WP3611	1/50	0.7191761136355437	1.0	0	0	0.7984031936127745	0.2631928213853386	MAP2K6
Synaptic Vesicle Pathway WP2267	1/51	0.7262283468670809	1.0	0	0	0.7827482290321318	0.25039394641742246	AP2S1
Integrated Breast Cancer Pathway WP1984	3/151	0.733042095304064	1.0	0	0	0.793115755244478	0.24630380295284887	GSK3A;PKIA;RPP38
Wnt Signaling Pathway WP363	1/52	0.7331038230789305	1.0	0	0	0.7676953784738216	0.23834480716831058	GSK3A
Toll-like Receptor Signaling Pathway WP75	2/103	0.7334575743155024	1.0	0	0	0.7751487316628878	0.24028488509006546	AKT2;MAP2K6
Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864	1/53	0.7398069641346819	1.0	0	0	0.7532105600120513	0.2269920431522448	SQSTM1
Phosphodiesterases in neuronal function WP4222	1/53	0.7398069641346819	1.0	0	0	0.7532105600120513	0.2269920431522448	ADCY3
Interferon type I signaling pathways WP585	1/54	0.7463420810958576	1.0	0	0	0.7392622163081245	0.21628685601701658	MAP2K6
Nonalcoholic fatty liver disease WP4396	3/155	0.7490372208191459	1.0	0	0	0.7726482518833302	0.2232695404149686	GSK3A;AKT2;COX6C
PI3K-Akt Signaling Pathway WP4172	7/340	0.7512934338746212	1.0	0	0	0.8218856404837385	0.23502557887893047	PPP2CB;CCNE2;AKT2;HGF;ITGA2;ITGAV;CREB5
Epithelial to mesenchymal transition in colorectal cancer WP4239	3/159	0.7642568290223569	1.0	0	0	0.7532105600120513	0.20250170049646027	AKT2;FZD7;MAP2K6
Complement and Coagulation Cascades WP558	1/58	0.7708848202585188	1.0	0	0	0.6882786151834263	0.17910131918603278	CR1
Wnt Signaling WP428	2/115	0.7870263090458474	1.0	0	0	0.6942636466198039	0.16627170117934442	FZD7;NKD1
Oxidation by Cytochrome P450 WP43	1/61	0.7877234230201977	1.0	0	0	0.6544288472235856	0.15615211331385975	CYP1A1
T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863	1/62	0.7930571802361636	1.0	0	0	0.6438735432361085	0.1492884899376393	CD4
Endometrial cancer WP4155	1/63	0.7982571785169429	1.0	0	0	0.6336533282641067	0.1427775906027392	AKT2
Spinal Cord Injury WP2431	2/118	0.7988481324232335	1.0	0	0	0.6766128759430292	0.151956712570033	LILRB3;AIF1
Cell Cycle WP179	2/120	0.8064031942160229	1.0	0	0	0.6653359946773121	0.14316129114537615	CDKN2D;CCNE2
Pathways Affected in Adenoid Cystic Carcinoma WP3651	1/65	0.8082692061884037	1.0	0	0	0.6141563027790573	0.13072937201049273	BCOR
Folate Metabolism WP176	1/66	0.8130876823459635	1.0	0	0	0.6048509042521019	0.1251535262116495	FOLR2
DNA Damage Response WP707	1/68	0.8223650772761623	1.0	0	0	0.5870611717740989	0.11481205212189051	CCNE2
RAC1/PAK1/p38/MMP2 Pathway WP3303	1/68	0.8223650772761623	1.0	0	0	0.5870611717740989	0.11481205212189051	TNIP2
mRNA Processing WP411	2/126	0.8275745077056185	1.0	0	0	0.6336533282641067	0.11992278063607874	U2AF2;CLASRP
Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341	1/71	0.8354265375051418	1.0	0	0	0.5622557701498412	0.10110081875554135	IFI27L2
miRNA Regulation of DNA Damage Response WP1530	1/71	0.8354265375051418	1.0	0	0	0.5622557701498412	0.10110081875554135	CCNE2
Chromosomal and microsatellite instability in colorectal cancer  WP4216	1/73	0.8435971539500546	1.0	0	0	0.546851502474503	0.09300861514188509	AKT2
VEGFA-VEGFR2 Signaling Pathway WP3888	4/236	0.8457707378331795	1.0	0	0	0.6766128759430292	0.11333736024282018	TNFRSF10C;ITGAV;TXN;MAP2K6
Peptide GPCRs WP24	1/74	0.8475293551605715	1.0	0	0	0.5394616173059287	0.08924302906068117	FPR1
DNA IR-damage and cellular response via ATR WP4016	1/80	0.8691348432663896	1.0	0	0	0.49900199600798406	0.06998852052755028	TP53BP1
Apoptosis WP254	1/84	0.8818125387723292	1.0	0	0	0.47523999619808	0.0597736843645364	IRF4
Mesodermal Commitment Pathway WP2857	2/147	0.8862034753881042	1.0	0	0	0.5431314242263772	0.06561500050226327	NCAPG2;PRKACA
GPCRs, Class A Rhodopsin-like WP455	4/257	0.8884380888276865	1.0	0	0	0.6213254425002136	0.07349678191901254	P2RY13;HRH2;PTAFR;FPR1
Retinoblastoma Gene in Cancer WP2446	1/87	0.8905095900420938	1.0	0	0	0.45885241012228417	0.05320917109797409	CCNE2
Regulation of Actin Cytoskeleton WP51	2/150	0.8928867574558603	1.0	0	0	0.5322687957418497	0.06030366866613291	GSN;WAS
Pancreatic adenocarcinoma pathway WP4263	1/89	0.89594976099645	1.0	0	0	0.44854112000717666	0.04928163353996171	AKT2
ErbB Signaling Pathway WP673	1/91	0.9011201371445045	1.0	0	0	0.4386830734136124	0.04567423074694301	AKT2
GPCRs, Other WP117	1/91	0.9011201371445045	1.0	0	0	0.4386830734136124	0.04567423074694301	P2RY13
Breast cancer pathway WP4262	2/154	0.9012316268083512	1.0	0	0	0.5184436322160874	0.05391449668652553	AKT2;FZD7
Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706	2/158	0.908967371773378	1.0	0	0	0.5053184769701105	0.048230667822650494	PRKACA;PPARGC1B
DNA Damage Response (only ATM dependent) WP710	1/110	0.9390866676427531	1.0	0	0	0.3629105425512611	0.02280802258172606	AKT2
Metapathway biotransformation Phase I and II WP702	2/183	0.945822340321872	1.0	0	0	0.4362858981490571	0.02430135510195566	NDST1;CYP1A1
Endoderm Differentiation WP2853	1/141	0.9723936918065935	1.0	0	0	0.283121699862686	0.007925857165803544	NCAPG2
Circadian rhythm related genes WP3594	1/201	0.9940524438845989	1.0	0	0	0.19860775960516777	0.001184757503910361	HOMER1
